Artificial Intelligence as an Emerging Technology in the Pharmaceutical Industry: What are the Legal Challenges? journal article Christian Tillmanns, Markus Fuderer European Pharmaceutical Law Review, Volume 3 (2019), Issue 1, Page 3 - 10 This article explores the possibilities and challenges of implementing emerging technologies in the form of Artificial Intelligence in the Pharmaceutical Industry under the current European legal framework governing medicinal products and medical devices. This includes among other things the question, to which degree an AI-programmer or the pharmaceutical manufacturer using such AI can be held liable for damages caused by the decisions of an autonomously acting AI-system.
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás